CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) [Phase 2]
Summary
A Phase 2 efficacy and safety study of MK0359 in rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED